FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

The FDA's approval of leucovorin highlights the ongoing efforts to expand treatment options for rare genetic disorders. However, the previous association with autism treatment raises questions about the drug's efficacy and the motivations behind its promotion. This duality in its application could lead to further scrutiny and discussion within the medical community regarding the appropriateness of its use in various contexts.